Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JPX Global | OTC Markets | Financial | Investment Holding Companies | US$1.17M | -1.1x | 0.04 | US$0.0007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Steakholder Foods PK | OTC Markets | Consumer Non-Cyclicals | Food & Tobacco | US$461.47K | -0x | -0 | US$0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rediff.com India | OTC Markets | Technology | Software & IT Services | US$5.18K | -0x | -0 | US$0.00010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ConneXionONE | OTC Markets | Technology | Software & IT Services | US$2.77M | -1.8x | 0 | US$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fineqia | OTC Markets | Technology | Financial Technology (Fintech) & Infrastructure | US$7.63M | -3.7x | US$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
RAADR | OTC Markets | Technology | Software & IT Services | US$10.19M | -3.3x | -2.01 | US$0.001 | -36.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voxeljet ADR | OTC Markets | US$3.01M | -0.2x | -0.01 | US$0.30 | -9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Standard Dental Labs | OTC Markets | Financial | Investment Holding Companies | US$11.64M | -21.6x | -0.38 | US$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aesthetic Medical Intl | OTC Markets | Healthcare | Healthcare Providers & Services | US$11.05M | -1.6x | -0.08 | US$0.23 | -61.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sagimet Biosciences | NASDAQ | Healthcare | Biotechnology & Medical Research | US$137.55M | -2.4x | -0.05 | US$5.19 | 20.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Singular Genomics Systems | NASDAQ | Healthcare | Biotechnology & Medical Research | US$36.01M | -0.4x | -0.08 | US$14.76 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.6% Downside | Upgrade to Pro+ | |
Leopard Energy | OTC Markets | Technology | Software & IT Services | US$280.04K | -1.1x | -0.01 | US$0.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eos Energy Enterprises | NASDAQ | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | US$682.09M | -4.5x | -0.07 | US$3.16 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
Palladyne AI | NASDAQ | Technology | Software & IT Services | US$65.85M | -0.8x | -0.01 | US$2.45 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -57.3% Downside | Upgrade to Pro+ | |
Lendingtree | NASDAQ | Financial | Banking Services | US$812.44M | -6.2x | -0.31 | US$60.78 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.9% Upside | Upgrade to Pro+ | |
Matterport | NASDAQ | Technology | Software & IT Services | US$1.53B | -5.6x | 0.61 | US$4.79 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.1% Upside | Upgrade to Pro+ | |
Monopar Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | US$19.50M | -2.4x | -0.07 | US$5.39 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
New Zealand Energy | OTC Markets | Energy | Oil & Gas | US$10.86M | -3x | 0.02 | US$0.86 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gevo | NASDAQ | Energy | Renewable Energy | US$462.48M | -6.4x | -0.26 | US$2 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -58.7% Downside | Upgrade to Pro+ | |
Babcock & Wilcox Enterprises | NYSE | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | US$235.56M | -1.2x | 0.01 | US$2.56 | 7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
2Seventy Bio | NASDAQ | Healthcare | Biotechnology & Medical Research | US$258M | -1.5x | -0.06 | US$5 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sitime Corp | NASDAQ | Technology | Semiconductors & Semiconductor Equipment | US$4.29B | -44.9x | 0.34 | US$185.14 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -24.3% Downside | Upgrade to Pro+ | |
Kaya Holdings | OTC Markets | Healthcare | Healthcare Providers & Services | US$982.26K | 0.6x | 0.01 | US$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Credo Technology Holding | NASDAQ | Technology | Semiconductors & Semiconductor Equipment | US$6.35B | -147.9x | -17.75 | US$38.16 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.5% Downside | Upgrade to Pro+ | |
GSE Systems | NASDAQ | Technology | Software & IT Services | US$14.44M | -1.7x | -0.03 | US$4.15 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Auxly Cannabis | OTC Markets | Healthcare | Pharmaceuticals | US$32.59M | -0.8x | -0.02 | US$0.03 | 9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sezzle | NASDAQ | Industrials | Professional & Commercial Services | US$1.01B | 18.7x | 0.06 | US$187.83 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Coherent | NYSE | Technology | Electronic Equipment & Parts | US$16.15B | 57x | -1.55 | US$102.58 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -18.8% Downside | Upgrade to Pro+ | |
Upstart | NASDAQ | Financial | Banking Services | US$4.86B | -23.7x | -0.73 | US$54.08 | 15% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -38.3% Downside | Upgrade to Pro+ | |
Aldeyra The | NASDAQ | Healthcare | Biotechnology & Medical Research | US$323.85M | -8.5x | -0.3 | US$5.44 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |